Medicare stopped paying hospitals for the added cost of treating patients who are injured in their care.
Last month Medicare stopped paying hospitals for the added cost of treating patients who are injured in their care, according to The New York Times (10/1/2008). The nation's largest insurer compiled a list of 10 "reasonably preventable" conditions for which it now refuses payment, including incompatible blood transfusions, treatment of infections after certain surgeries, a second surgery to remove a left-behind sponge, serious bed sores, and injuries from falls and urinary tract infections caused by catheters. The regulations could apply to several hundred thousand of the 12.5 million hospital stays Medicare covers annually. The policy also would prohibit hospitals from billing patients directly for costs generated by medical errors.
Other insurers, both public and private, have similar restrictions in place. Last year, four state Medicaid programs announced that they will not pay for as many as 28 events. Some of the country's largest commercial insurers, including WellPoint, Aetna, Cigna, and Blue Cross Blue Shield plans in seven states, have similar restrictions. In addition, some state hospital associations have brokered voluntary agreements that members will not bill for medical errors. Maine is the first state to pass a statute banning the practice.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More